111 related articles for article (PubMed ID: 19839796)
1. Encapsulation of complex extracts in beta-cyclodextrin: an application to propolis ethanolic extract.
Kalogeropoulos N; Konteles S; Mourtzinos I; Troullidou E; Chiou A; Karathanos VT
J Microencapsul; 2009 Nov; 26(7):603-13. PubMed ID: 19839796
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of nutraceutical monoterpenes in beta-cyclodextrin and modified starch.
Mourtzinos I; Kalogeropoulos N; Papadakis SE; Konstantinou K; Karathanos VT
J Food Sci; 2008 Jan; 73(1):S89-94. PubMed ID: 18211376
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation of olive leaf extract in beta-cyclodextrin.
Mourtzinos I; Salta F; Yannakopoulou K; Chiou A; Karathanos VT
J Agric Food Chem; 2007 Oct; 55(20):8088-94. PubMed ID: 17764146
[TBL] [Abstract][Full Text] [Related]
5. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
6. Bioactive permethrin/beta-cyclodextrin inclusion complex.
Yang GF; Wang HB; Yang WC; Gao D; Zhan CG
J Phys Chem B; 2006 Apr; 110(13):7044-8. PubMed ID: 16571020
[TBL] [Abstract][Full Text] [Related]
7. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
Garnero C; Longhi M
J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
9. Phase solubility studies and stability of cholesterol/β-cyclodextrin inclusion complexes.
dos Santos C; Buera MP; Mazzobre MF
J Sci Food Agric; 2011 Nov; 91(14):2551-7. PubMed ID: 21538367
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
14. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
[TBL] [Abstract][Full Text] [Related]
15. Study of the physicochemical properties of trimethoprim with beta-cyclodextrin in solution.
Li N; Zhang YH; Xiong XL; Li ZG; Jin XH; Wu YN
J Pharm Biomed Anal; 2005 Jun; 38(2):370-4. PubMed ID: 15925234
[TBL] [Abstract][Full Text] [Related]
16. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
17. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
18. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of gastric toxicity of indomethacin acid, salt form and complexed forms with hydroxypropyl-beta-cyclodextrin on Wistar rats: histopathologic analysis.
Ribeiro-Rama AC; Figueiredo IV; Veiga F; Castel-Branco MM; Cabrita AM; Caramona MM
Fundam Clin Pharmacol; 2009 Dec; 23(6):747-55. PubMed ID: 19656206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
